NorthWest Biotherapeutics Inc (NWBO)

[FeMike]

That is where you and I disagree. This signaling is nonsense because it really is not in the hands of NWBO. I mean NWBO can do dumb things such as submitting a PIP redesign to the MHRA in the middle of the MHRA's decision timeline risking an MHRA pause or other stupid things to slow the decision timeline down, but NWBO does NOT know when the decision is made and therefore the suggestion of signaling is silly.

But you still can't give me any solid reasons why NWBO would include that in the 10K knowing full well it would hurt the share price.

NWBO has never, to my knowledge, commented on their ASCO presence in their financial reporting. Why start now? They could have easily left that information out and I guarantee the market doesn't react as poorly to the K as it did.

Didn't they pull their abstract last year as well? I want to say they had a placeholder and pulled out, didn't comment on it then. They still attended the conference, but still.

Honestly, had they pulled out without telling anyone, the pumping that would have gone on around it probably would have been off the charts. Speculation would have run rampant about what pulling out meant. There would have been some FUD around it as well, no doubt, but the interwebs would have been buzzing the same way they are buzzing now about the Stuttgart suspension. "Must mean news coming. Must mean approval done. Must mean buyout/acquisition. etc etc".

But no, now the only thing people think is what NWBO actually said, which is that they aren't attending ASCO in June so that they can continue working on the MAA. The quote:

The Company continued working with teams of specialized consultants on the MAA process, including onsite inspections in the U.K. and U.S., and ongoing production of documents and information before, during and after the inspections. The Company is actively engaged in the ongoing process, and the Company has decided not to attend ASCO this year (in June) in order to stay focused on interactions with the MHRA and efforts to move forward as quickly as possible.

So I agree with you, and that quote does not necessarily mean they plan to still be interacting with the MHRA, and could indeed mean they are busy with ASCO prep now and don't want to be burdened with it (I doubt it, they weren't doing anything at ASCO they haven't done in years past, but I concede it could be that). But even so, the way it more than easily reads is that ASCO is in June. They don't want to do ASCO because they want to stay focused on interactions with the MHRA. They think they'll still be interacting with MHRA when ASCO is scheduled.

It's not truth that matters, it is perception. So either NWBO is AWFUL at perception (very possible) and don't think the decision will extend out to ASCO they just didn't realize how stupid it would be to put a phrase like that in the 10K, or they understand what the perception would be and it is exactly what they meant and the reason the put it in there. There's really no middle ground here. My inclination is that they meant what they said (they usually do, oddly enough). I don't discount the other theory, that they just gaffed it up big time, and approval could still come any day.

Either way, my point stands, it's not great to have that in the 10K unnecessarily. And I disagree with you that NWBO doesn't have a much better idea of when this could happen than retail shareholders. They may not know exactly, but I guarantee they've got a pretty strong idea of the general timeframe (days, weeks, months, etc).